UnitedHealth Group will follow the CDC recommendations and state or local guidance on vaccine prioritization to support the most effective vaccine distribution for our employees and the communities we serve. As COVID-19 vaccines continue to become more widely available, we are committed to providing you with the most current information:
- The CDC and FDA directed a pause on the administration of the Johnson & Johnson (J&J) vaccine, Janssen, at federal vaccination sites and recommended that states follow the same guidance. This recommendation is in response to six cases of cerebral venous thrombosis (blood clots) and low blood platelets that have been reported out of the seven million persons vaccinated in the U.S. All six individuals were women ages 18 to 48 who developed issues 6 to 13 days following the vaccination. The pause on vaccination is recommended until experts from the CDC’s Advisory Council on Infection Prevention can review the details of the six cases and provide further guidance. During this time, providers will also be trained to recognize the signs and treat the symptoms of these extremely rare side effects. If you recently received the J&J vaccine, the FDA recommends you monitor for severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination and contact your health care provider if you develop any of these symptoms. For up to date information, please visit the CDC website.